Description
Gina Columbus reports on FDA approvals in follicular lymphoma and prostate cancer, a biosimilar approved for several cancers, a new drug application in prostate cancer, results from 2 late-stage prostate cancer trials, and encouraging findings in a chronic lymphocytic leukemia study.
Tags
cancer oncology